Peter Schneider

Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA.

ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA.

Innovasc LLC provides a treatment platform comprised of two devices that enable drug-eluting balloon therapy. It focuses on the development of alternatives to stent technology. The firm's products permit minimal injury balloon angioplasty and minimal footprint tacking of blood vessel blockages. The company was founded by Peter Schneider and Robert Giasolli in 2007 and is headquartered in Honolulu, HI.

Hawaii Permanente Medical Group, Inc. provides primary healthcare services. The private company is based in Honolulu, HI. The CEO of the company is Ramin Davidoff.

American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX.